P277 The novel CFAbd-Score.kid reveals a significant decline in abdominal symptoms in children with cystic fibrosis aged 6-<12 years on a new therapy with elexacaftor/tezacaftor/ivacaftor

Saved in:
Bibliographic Details
Published in:Journal of cystic fibrosis 2024-06, Vol.23, p.S154-S154
Main Authors: Mainz, J.G, Zagoya, C, Bechinger, L, Duckstein, F, Barucha, A, Polte, L, Nährlich, L, Simon, A, Eickmeier, O, van Dullemen, S, Graepler-Mainka, U, Sadrieh, P
Format: Article
Language:English
Subjects:
Pulmonary/Respiratory
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1569-1993
1873-5010
DOI:10.1016/S1569-1993(24)00578-2